Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Merck & Co., Inc.    MRK

MERCK & CO., INC.

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Most relevant news about MERCK & CO., INC.
09:15aMERCK & CO., INC. : quaterly earnings release
08:03aMERCK : Donates $500,000 to Support River Blindness and Lymphatic Filariasis Eli..
BU
05:45aCovid-19 Vaccine Makers to Face Challenges When Recognizing Revenue
DJ
10/21MERCK : Announces Positive Topline Results from Two Additional Phase 3 Adult Stu..
AQ
10/21MERCK : to Present New Data from its Extensive Infectious Diseases and Vaccines ..
BU
10/20MERCK : and Sanofi to Present Three New Studies Highlighting Combination Pediatr..
PU
10/20MERCK : Reports More Positive Phase 3 Study Results for V114 Vaccine
DJ
10/20MERCK : Announces Positive Topline Results from Two Additional Phase 3 Adult Stu..
BU
10/16MERCK : Presents Three-Year Survival Data for KEYTRUDA® (pembrolizumab) in Combi..
BU
10/16MERCK : FDA Approves Expanded Indication for Merck's KEYTRUDA in Adult Patients ..
AQ
10/15MERCK : Issues 2019, 2020 Corporate Responsibility Report
AQ
10/15MERCK : Gets FDA Expanded Approval for Keytruda in Classical Hodgkin Lymphoma
DJ
10/15MERCK : Health Canada Approves KEYTRUDA® (pembrolizumab) as First-line Treatment..
AQ
10/15MERCK : FDA Approves Expanded Indication for Merck's KEYTRUDA® (pembrolizumab) i..
BU
10/14MERCK : Announces Plans to Construct New Facility in the United States to Expand..
PU
More most relevant news
All news about MERCK & CO., INC.
09:15aMERCK & CO., INC. : quaterly earnings release
08:03aMERCK : Donates $500,000 to Support River Blindness and Lymphatic Filariasis Eli..
BU
05:45aCovid-19 Vaccine Makers to Face Challenges When Recognizing Revenue
DJ
10/21MERCK : Announces Positive Topline Results from Two Additional Phase 3 Adult Stu..
AQ
10/21SANOFI : Merck and Sanofi to Present Three New Studies Highlighting Combination ..
AQ
10/21MERCK : to Present New Data from its Extensive Infectious Diseases and Vaccines ..
BU
10/20MERCK : and Sanofi to Present Three New Studies Highlighting Combination Pediatr..
PU
10/20MERCK : Reports More Positive Phase 3 Study Results for V114 Vaccine
DJ
10/20MERCK : Announces Positive Topline Results from Two Additional Phase 3 Adult Stu..
BU
10/16MERCK : Presents Three-Year Survival Data for KEYTRUDA® (pembrolizumab) in Combi..
BU
More news
News in other languages on MERCK & CO., INC.
02:45aMERCK & CO., INC. : Veröffentlichung des Quartalsergebnisses
02:45aMERCK & CO., INC. : publication des résultats trimestriels
10/21MERCK : va partager les résultats de ses recherches
10/20MERCK : essais encourageants du vaccin anti-pneumococcique
10/15MERCK : des progrès dans le traitement du lymphome hodgkinien
10/08MERCK : résultats encourageants pour un traitement du VIH
10/02MERCK : changement à la tête du laboratoire de recherche
10/01Fachjournale werfen US-Arzneimittelbehörde FDA Nachlässigkeit vor
09/28MERCK : lance une campagne mondiale contre la rage
09/14US-Konzern Merck & Co steigt für Krebsmittelforschung bei Seattle Genetics ei..
Analyst Recommendations on MERCK & CO., INC.
01/07MERCK & CO INC : RBC gives a Neutral rating
MD
2019MERCK & CO INC : Goldman Sachs remains Neutral
MD
2019MERCK & CO INC : JP Morgan remains Neutral
MD
2017Germany's Merck hires JP Morgan to sell consumer health
RE
More recommendations
Press releases
08:03aMERCK : Donates $500,000 to Support River Blindness and Lymphatic Filariasis Eli..
BU
10/21SANOFI : Merck and Sanofi to Present Three New Studies Highlighting Combination ..
AQ
10/21MERCK : Announces Positive Topline Results from Two Additional Phase 3 Adult Stu..
AQ
10/21MERCK : to Present New Data from its Extensive Infectious Diseases and Vaccines ..
BU
10/20MERCK : and Sanofi to Present Three New Studies Highlighting Combination Pediatr..
PU
More press releases
Analysis
Merck to move COVID-19 treatment into large trials, sees sales recovering this year
Stock Pick
 MERCK AND COMPANY
Leader in oncology, modest valuation
Stock Trading Strategies
TRADING
 The underlying trend is to the upside
Upcoming event on MERCK & CO., INC.
10/27/20Q3 2020 Earnings Call
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Categories
Free services
Mobile App
SOLUTIONS
About
Stock Market Quotes Interactive brokers Offre Binck Best of des tweets Stock Market News Börse: Aktien, Kurse und Nachrichten
Copyright © 2020 Surperformance. All rights reserved. Les cotations sont fournies par Factset, Morningstar,S&P Capital IQ et vwd Group